Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 44601-44650 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05586243
MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3)
N/ARecruiting
5 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06252337
Survival and Success of Two Different Filling Techniques
NARecruiting
80 participants
Started: Jan 1, 2023 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT06276959
The Effectiveness of iTero Element 5D NIRI System in Early Proximal Caries Detection in Permanent Teeth
N/ARecruiting
120 participants
Started: Jan 1, 2023 · Completed: Mar 1, 2025
1 condition1 sponsor1 location
NCT05587725
Human Papillomavirus in Young People Epidemiological Research 3
N/ARecruiting
200 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2025
7 conditions3 sponsors1 location
NCT04831398
The Effects of Acute Melatonin Supplementation on Cardiovascular Responses to Sympathetic Activation
PHASE4Recruiting
100 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05651802
PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients
NARecruiting
220 participants
Started: Jan 1, 2023 · Completed: Jun 30, 2026
1 condition3 sponsors2 locations
NCT05491837
Effects of Intermittent Hypoxia in Upper and Lower Limb Functions in Persons With Incomplete Spinal Cord Injury
NARecruiting
68 participants
Started: Jan 1, 2023 · Completed: Nov 4, 2024
1 condition1 sponsor1 location
NCT05852197
Effect of Anticoagulant Drug Intervention on Postoperative MALE and MACE in Patients With PAD
N/ARecruiting
6,000 participants
Started: Jan 1, 2023 · Completed: Jan 1, 2026
3 conditions1 sponsor1 location
NCT05726942
Efficacy of mHealth Applications in Weight Management in a Population Affected by Overweight or Obesity
NARecruiting
30 participants
Started: Jan 1, 2023 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT07065734
NEgative prEssure Wound Therapy in Renal Transplant
PHASE4Recruiting
150 participants
Started: Jan 1, 2023 · Completed: Jun 30, 2026
3 conditions2 sponsors1 location
NCT05824962
A Non-invasive Diagnostic Model for Intestinal Fibrosis in Crohn's Disease Based on 18F-FAPI PET Imaging
N/ARecruiting
50 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05832320
Optimum Induction Therapy of Low-risk APL
NARecruiting
74 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT05800223
Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer
PHASE3Recruiting
300 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06079333
NEO- and Adjuvant Targeted Therapy in Braf-mutated Anaplastic Cancer of the Thyroid (NEO-ATACT Study)
PHASE2Recruiting
20 participants
Started: Jan 1, 2023 · Completed: Jan 1, 2028
1 condition2 sponsors1 location
NCT06121388
Brain MRI Imaging Changes and Associated Factors on Cognition Function in Patients With Premature Ovarian Failure
N/ARecruiting
100 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05957679
MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment
NARecruiting
20 participants
Started: Jan 1, 2023 · Completed: Sep 1, 2026
1 condition1 sponsor1 location
NCT06260241
Gain in Stretched Penile Length After Phalloplasty With & Without Penile Traction in Children.
NARecruiting
70 participants
Started: Jan 1, 2023 · Completed: Jan 1, 2025
1 condition1 sponsor1 location
NCT05830812
Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma
N/ARecruiting
3,000 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06032910
Surgical Mesh in Radical Cystectomy to Prevent Parastomal Hernias
NARecruiting
25 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT06038409
Ketamine Treatment Plans for Chronic Conditions
N/ARecruiting
500 participants
Started: Jan 1, 2023 · Completed: Jun 1, 2029
4 conditions1 sponsor1 location
NCT06593132
Single Port Endoscopic Breast Conserving Surgery
N/ARecruiting
200 participants
Started: Jan 1, 2023 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT05265429
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
N/ARecruiting
500 participants
Started: Jan 1, 2023 · Completed: Aug 1, 2027
3 conditions1 sponsor4 locations
NCT05629832
Transpulmonary Pressure in Right Ventricle Protection of ARDS
NARecruiting
40 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06273176
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
N/ARecruiting
225 participants
Started: Jan 1, 2023 · Completed: Jan 1, 2028
9 conditions8 sponsors8 locations
NCT05596578
Role of Intrapulmonary Lymph Nodes in Patients With NSCLC and Visceral Pleural Invasion
N/ARecruiting
958 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT06277024
A Study on the Safety and Efficacy of the Combination of Candenizumab, Lenvatinib, and SOX Regimen in the Treatment of HER2 Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Patients
NARecruiting
50 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05024409
Cerebral Palsy Upper Extremity Orthotic Device
NARecruiting
36 participants
Started: Jan 1, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor2 locations
NCT06430970
Prevalence Of Significant Endoscopic and Histopathologic Findings in Patients Presenting With Unexplained Iron Deficiency Anemia
NARecruiting
124 participants
Started: Jan 1, 2023 · Completed: Jan 1, 2025
1 condition1 sponsor1 location
NCT05640830
Trastuzumab, Bevacizumab with Paclitaxel for HER2-positive Gastric Cancer in a Second-line Therapy
PHASE1/PHASE2Recruiting
47 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05978193
Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
PHASE2Recruiting
160 participants
Started: Jan 1, 2023 · Completed: Jan 1, 2027
3 conditions1 sponsor2 locations
NCT06045039
Clinical Efficacy of Stent-balloon-stent (SBS) Technique in the Treatment of Coronary Bifurcation Lesions
N/ARecruiting
200 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2024
5 conditions1 sponsor1 location
NCT06252324
Success and Survival Rate of Tranmucosal Versus Bone Level Implants: Randomized Clinical Trial
NARecruiting
80 participants
Started: Jan 1, 2023 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05179356
Dapagliflozin in Pulmonary Arterial Hypertension
PHASE2Recruiting
52 participants
Started: Jan 1, 2023 · Completed: Sep 30, 2024
2 conditions1 sponsor1 location
NCT05530512
Acupuncture Therapy and Hypertension
NARecruiting
72 participants
Started: Jan 1, 2023 · Completed: Mar 31, 2027
1 condition2 sponsors2 locations
NCT04777175
A Retrospective Study: Evaluation of the Efficacy of Immunotherapy With Rare Mutations in Non-small Cell Lung Cancer
N/ARecruiting
186 participants
Started: Jan 1, 2023 · Completed: Jan 12, 2025
1 condition2 sponsors2 locations
NCT05923645
Efficacy of rTMS as an Adjunct to AI Enabled Remedial Intervention in Children With Dyslexia
NARecruiting
60 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05559151
Effect and Mechanism of Remimazolam Benzenesulfonate on Enhanced Recovery After Surgery in Patients Undergoing Radical Gastrectomy for Gastric Cancer
NARecruiting
60 participants
Started: Jan 1, 2023 · Completed: Dec 1, 2025
2 conditions2 sponsors1 location
NCT05535413
UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases
PHASE1/PHASE2Recruiting
30 participants
Started: Jan 1, 2023 · Completed: Jul 31, 2025
4 conditions1 sponsor1 location
NCT04960839
Prophylactic Irradiation to the Contralateral Breast for BCAs Patients
NARecruiting
323 participants
Started: Jan 1, 2023 · Completed: Dec 1, 2029
1 condition1 sponsor8 locations
NCT06156553
School-based Intervention to Support Active Travel
NARecruiting
200 participants
Started: Jan 1, 2023 · Completed: Jun 30, 2027
2 conditions5 sponsors1 location
NCT06169072
Sentinel Lymph Node Localisation With an Ultra-low Dose of Magtrace in Breast Cancer Patients
PHASE2Recruiting
220 participants
Started: Jan 1, 2023 · Completed: Jul 1, 2027
2 conditions1 sponsor1 location
NCT05424406
Role of Sleep Reactivity in Shift Work Disorder
NARecruiting
150 participants
Started: Jan 1, 2023 · Completed: Oct 1, 2027
1 condition2 sponsors1 location
NCT04781933
"Interest in Combo (a Combination of Dietary Supplements Including Probiotics) in NASH Improvement"
NARecruiting
60 participants
Started: Jan 1, 2023 · Completed: Jan 1, 2025
1 condition1 sponsor2 locations
NCT04080934
Breaststroke Swimming After Breast Cancer Treatment/Surgery as a Means of Treatment for Seroma, Lymphedema, and Chronic Arm and Chest Pain
NARecruiting
128 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2025
4 conditions3 sponsors1 location
NCT06289543
Preoperative Oral Carbohydrate on Gastric Emptying
NARecruiting
120 participants
Started: Jan 1, 2023 · Completed: Apr 15, 2024
2 conditions1 sponsor1 location
NCT06171308
Effect of Moxibustion Intervention on Insomnia Patients
NARecruiting
120 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05867004
Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma
N/ARecruiting
100 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT05593549
Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
EARLY_PHASE1Recruiting
60 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT07156058
MiniPDX-based Postoperative Adjuvant Therapy for Biliary Tract Cancer
NARecruiting
204 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06993636
Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years
N/ARecruiting
60 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location